To further confirm the mode of cell death promoted by the knockdown of ACLY in CCA cells under RSL3 treatment, we treated cells with the ferroptosis inhibitor ferrostatin-1 (Ferr-1). The gene discussed is ACLY; the disease is cholangiocarcinoma.